Zentiva (BSE:SCD) Total Equity: lei1,497 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSE:SCD Zentiva SA BSE:SCD
10 GF Score
Price lei4.52
View Full Analysis

What is Zentiva Total Equity?

Zentiva BSE:SCD 10 Total Equity is lei1,497 Mil as of Mar. 2025. GuruFocus rates BSE:SCD with a GF Score™ of 10/100.

Zentiva's total equity for the quarter that ended in Mar. 2025 was lei1,497 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Zentiva Total Equity Historical Data

* Premium members only.

The historical data trend for Zentiva's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zentiva Total Equity Chart

Zentiva Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 785.36 890.77 999.36 1,191.26 1,441.59

Zentiva Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,265.43 1,333.85 1,392.86 1,441.59 1,496.81
BSE:SCD
10GF Score
Zentiva SA BSE:SCD
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zentiva Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Zentiva's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=1733.725-292.139
=1,442

Zentiva's Total Equity for the quarter that ended in Mar. 2025 is calculated as

Total Equity=Total Assets(Q: Mar. 2025 )-Total Liabilities(Q: Mar. 2025 )
=1847.412-350.599
=1,497

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of lei1,497 Mil mean?
Zentiva (BSE:SCD) has a Total Equity of lei1,497 Mil as of Mar. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Zentiva and its competitors.
Is Zentiva's Total Equity too high?
Zentiva's current Total Equity is lei1,497 Mil. Overall, Zentiva has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Zentiva's Total Equity compare to ZTS and VTRS?
Zentiva's Total Equity of lei1,497 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Zentiva and its competitors. Zentiva's current Total Equity is lei1,497 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zentiva stock overvalued right now?
Zentiva (BSE:SCD) has a current Total Equity of lei1,497 Mil. The current Total Equity is lei1,497 Mil. Zentiva's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Zentiva (BSE:SCD), the current Total Equity is lei1,497 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zentiva Business Description

Address No. 50, Theodor Pallady Boulevard, Sector 3, Bucharest, ROU, 032266
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.
10GF Score

Get the complete analysis for BSE:SCD

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei4.52
Price